Novo Nordisk's Wegovy HD has received FDA approval. The company has been dealing with patent expiries and disputes, including a loss in a patent dispute and the expiration of a patent in India, which has led to the introduction of cheaper alternatives. Meanwhile, Novo Nordisk has also launched a higher-dose version of Wegovy in the US and received approval for the drug's use in fatty liver disease in India.